aluates Reports

$ 0.0

Automative

Global Pharmaceutical CXO Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-4A10478

Global Pharmaceutical CXO Market Insights Forecast to 2028

BUY CHAPTERS

Global Pharmaceutical CXO Market Research Report 2025

Code: QYRE-Auto-4A10478

Report

July 2025

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

WuXi AppTec

Tigermed

Charles River Laboratories

Pharmaron

Boehringer Ingelheim

GenScript

MabPlex International

Wuxi Biologics

Jiuzhou Pharma

IQVIA

Syneos Health

PAREXEL

AGC Biologics

FUJIFILM Diosynth Biotechnologies

Patheon

Catalent

Lonza Group AG

Avid Bioservices

AbbVie

Labcorp Drug Development

Shanghai ChemPartner

Pharmablock

Asym Chemical

Pharmaceutical CXO Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmaceutical CXO Market

The global market for Pharmaceutical CXO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract manufacturing services (CDMO) and CMO.

In the process of new drug development, through pharmaceutical contract outsourcing, pharmaceutical companies or biotechnology companies commission drug R&D and production companies to provide professional R&D services, including technical process development, API and CCMO production, formulation production, etc.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CXO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CXO.

The Pharmaceutical CXO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical CXO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical CXO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmaceutical CXO Market Report

Report Metric	Details
Report Name	Pharmaceutical CXO Market
CAGR	5%
Segment by Type	CRO CMO CDMO
Segment by Application	Pharmaceutical Companies Biotechnology Companies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	WuXi AppTec, Tigermed, Charles River Laboratories, Pharmaron Inc, Labcorp Drug Development, Boehringer Ingelheim, GenScript, MabPlex International, Shanghai ChemPartner, Wuxi Biologics, Pharmablock, Jiuzhou Pharma, Asym Chemical, IQVIA, Syneos Health, Parexel, AGC Biologics, FUJIFILM Diosynth Biotechnologies, Patheon, Catalent, Lonza Group AG, Avid Bioservices, AbbVie
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical CXO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical CXO Market report?

Ans: The main players in the Pharmaceutical CXO Market are WuXi AppTec, Tigermed, Charles River Laboratories, Pharmaron Inc, Labcorp Drug Development, Boehringer Ingelheim, GenScript, MabPlex International, Shanghai ChemPartner, Wuxi Biologics, Pharmablock, Jiuzhou Pharma, Asym Chemical, IQVIA, Syneos Health, Parexel, AGC Biologics, FUJIFILM Diosynth Biotechnologies, Patheon, Catalent, Lonza Group AG, Avid Bioservices, AbbVie

What are the Application segmentation covered in the Pharmaceutical CXO Market report?

Ans: The Applications covered in the Pharmaceutical CXO Market report are Pharmaceutical Companies, Biotechnology Companies

What are the Type segmentation covered in the Pharmaceutical CXO Market report?

Ans: The Types covered in the Pharmaceutical CXO Market report are CRO, CMO, CDMO

Recommended Reports

CXO & CRO Services

Drug Delivery & Types

Pharmaceutical Chain Solutions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical CXO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CRO

1.2.3 CMO

1.2.4 CDMO

1.3 Market by Application

1.3.1 Global Pharmaceutical CXO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Companies

1.3.3 Biotechnology Companies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical CXO Market Perspective (2020-2031)

2.2 Global Pharmaceutical CXO Growth Trends by Region

2.2.1 Global Pharmaceutical CXO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmaceutical CXO Historic Market Size by Region (2020-2025)

2.2.3 Pharmaceutical CXO Forecasted Market Size by Region (2026-2031)

2.3 Pharmaceutical CXO Market Dynamics

2.3.1 Pharmaceutical CXO Industry Trends

2.3.2 Pharmaceutical CXO Market Drivers

2.3.3 Pharmaceutical CXO Market Challenges

2.3.4 Pharmaceutical CXO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceutical CXO Players by Revenue

3.1.1 Global Top Pharmaceutical CXO Players by Revenue (2020-2025)

3.1.2 Global Pharmaceutical CXO Revenue Market Share by Players (2020-2025)

3.2 Global Pharmaceutical CXO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmaceutical CXO Revenue

3.4 Global Pharmaceutical CXO Market Concentration Ratio

3.4.1 Global Pharmaceutical CXO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CXO Revenue in 2024

3.5 Global Key Players of Pharmaceutical CXO Head office and Area Served

3.6 Global Key Players of Pharmaceutical CXO, Product and Application

3.7 Global Key Players of Pharmaceutical CXO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical CXO Breakdown Data by Type

4.1 Global Pharmaceutical CXO Historic Market Size by Type (2020-2025)

4.2 Global Pharmaceutical CXO Forecasted Market Size by Type (2026-2031)

5 Pharmaceutical CXO Breakdown Data by Application

5.1 Global Pharmaceutical CXO Historic Market Size by Application (2020-2025)

5.2 Global Pharmaceutical CXO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharmaceutical CXO Market Size (2020-2031)

6.2 North America Pharmaceutical CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmaceutical CXO Market Size by Country (2020-2025)

6.4 North America Pharmaceutical CXO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmaceutical CXO Market Size (2020-2031)

7.2 Europe Pharmaceutical CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmaceutical CXO Market Size by Country (2020-2025)

7.4 Europe Pharmaceutical CXO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceutical CXO Market Size (2020-2031)

8.2 Asia-Pacific Pharmaceutical CXO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmaceutical CXO Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmaceutical CXO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmaceutical CXO Market Size (2020-2031)

9.2 Latin America Pharmaceutical CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmaceutical CXO Market Size by Country (2020-2025)

9.4 Latin America Pharmaceutical CXO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceutical CXO Market Size (2020-2031)

10.2 Middle East & Africa Pharmaceutical CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmaceutical CXO Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmaceutical CXO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 WuXi AppTec

11.1.1 WuXi AppTec Company Details

11.1.2 WuXi AppTec Business Overview

11.1.3 WuXi AppTec Pharmaceutical CXO Introduction

11.1.4 WuXi AppTec Revenue in Pharmaceutical CXO Business (2020-2025)

11.1.5 WuXi AppTec Recent Development

11.2 Tigermed

11.2.1 Tigermed Company Details

11.2.2 Tigermed Business Overview

11.2.3 Tigermed Pharmaceutical CXO Introduction

11.2.4 Tigermed Revenue in Pharmaceutical CXO Business (2020-2025)

11.2.5 Tigermed Recent Development

11.3 Charles River Laboratories

11.3.1 Charles River Laboratories Company Details

11.3.2 Charles River Laboratories Business Overview

11.3.3 Charles River Laboratories Pharmaceutical CXO Introduction

11.3.4 Charles River Laboratories Revenue in Pharmaceutical CXO Business (2020-2025)

11.3.5 Charles River Laboratories Recent Development

11.4 Pharmaron Inc

11.4.1 Pharmaron Inc Company Details

11.4.2 Pharmaron Inc Business Overview

11.4.3 Pharmaron Inc Pharmaceutical CXO Introduction

11.4.4 Pharmaron Inc Revenue in Pharmaceutical CXO Business (2020-2025)

11.4.5 Pharmaron Inc Recent Development

11.5 Labcorp Drug Development

11.5.1 Labcorp Drug Development Company Details

11.5.2 Labcorp Drug Development Business Overview

11.5.3 Labcorp Drug Development Pharmaceutical CXO Introduction

11.5.4 Labcorp Drug Development Revenue in Pharmaceutical CXO Business (2020-2025)

11.5.5 Labcorp Drug Development Recent Development

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Details

11.6.2 Boehringer Ingelheim Business Overview

11.6.3 Boehringer Ingelheim Pharmaceutical CXO Introduction

11.6.4 Boehringer Ingelheim Revenue in Pharmaceutical CXO Business (2020-2025)

11.6.5 Boehringer Ingelheim Recent Development

11.7 GenScript

11.7.1 GenScript Company Details

11.7.2 GenScript Business Overview

11.7.3 GenScript Pharmaceutical CXO Introduction

11.7.4 GenScript Revenue in Pharmaceutical CXO Business (2020-2025)

11.7.5 GenScript Recent Development

11.8 MabPlex International

11.8.1 MabPlex International Company Details

11.8.2 MabPlex International Business Overview

11.8.3 MabPlex International Pharmaceutical CXO Introduction

11.8.4 MabPlex International Revenue in Pharmaceutical CXO Business (2020-2025)

11.8.5 MabPlex International Recent Development

11.9 Shanghai ChemPartner

11.9.1 Shanghai ChemPartner Company Details

11.9.2 Shanghai ChemPartner Business Overview

11.9.3 Shanghai ChemPartner Pharmaceutical CXO Introduction

11.9.4 Shanghai ChemPartner Revenue in Pharmaceutical CXO Business (2020-2025)

11.9.5 Shanghai ChemPartner Recent Development

11.10 Wuxi Biologics

11.10.1 Wuxi Biologics Company Details

11.10.2 Wuxi Biologics Business Overview

11.10.3 Wuxi Biologics Pharmaceutical CXO Introduction

11.10.4 Wuxi Biologics Revenue in Pharmaceutical CXO Business (2020-2025)

11.10.5 Wuxi Biologics Recent Development

11.11 Pharmablock

11.11.1 Pharmablock Company Details

11.11.2 Pharmablock Business Overview

11.11.3 Pharmablock Pharmaceutical CXO Introduction

11.11.4 Pharmablock Revenue in Pharmaceutical CXO Business (2020-2025)

11.11.5 Pharmablock Recent Development

11.12 Jiuzhou Pharma

11.12.1 Jiuzhou Pharma Company Details

11.12.2 Jiuzhou Pharma Business Overview

11.12.3 Jiuzhou Pharma Pharmaceutical CXO Introduction

11.12.4 Jiuzhou Pharma Revenue in Pharmaceutical CXO Business (2020-2025)

11.12.5 Jiuzhou Pharma Recent Development

11.13 Asym Chemical

11.13.1 Asym Chemical Company Details

11.13.2 Asym Chemical Business Overview

11.13.3 Asym Chemical Pharmaceutical CXO Introduction

11.13.4 Asym Chemical Revenue in Pharmaceutical CXO Business (2020-2025)

11.13.5 Asym Chemical Recent Development

11.14 IQVIA

11.14.1 IQVIA Company Details

11.14.2 IQVIA Business Overview

11.14.3 IQVIA Pharmaceutical CXO Introduction

11.14.4 IQVIA Revenue in Pharmaceutical CXO Business (2020-2025)

11.14.5 IQVIA Recent Development

11.15 Syneos Health

11.15.1 Syneos Health Company Details

11.15.2 Syneos Health Business Overview

11.15.3 Syneos Health Pharmaceutical CXO Introduction

11.15.4 Syneos Health Revenue in Pharmaceutical CXO Business (2020-2025)

11.15.5 Syneos Health Recent Development

11.16 Parexel

11.16.1 Parexel Company Details

11.16.2 Parexel Business Overview

11.16.3 Parexel Pharmaceutical CXO Introduction

11.16.4 Parexel Revenue in Pharmaceutical CXO Business (2020-2025)

11.16.5 Parexel Recent Development

11.17 AGC Biologics

11.17.1 AGC Biologics Company Details

11.17.2 AGC Biologics Business Overview

11.17.3 AGC Biologics Pharmaceutical CXO Introduction

11.17.4 AGC Biologics Revenue in Pharmaceutical CXO Business (2020-2025)

11.17.5 AGC Biologics Recent Development

11.18 FUJIFILM Diosynth Biotechnologies

11.18.1 FUJIFILM Diosynth Biotechnologies Company Details

11.18.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.18.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Introduction

11.18.4 FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CXO Business (2020-2025)

11.18.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.19 Patheon

11.19.1 Patheon Company Details

11.19.2 Patheon Business Overview

11.19.3 Patheon Pharmaceutical CXO Introduction

11.19.4 Patheon Revenue in Pharmaceutical CXO Business (2020-2025)

11.19.5 Patheon Recent Development

11.20 Catalent

11.20.1 Catalent Company Details

11.20.2 Catalent Business Overview

11.20.3 Catalent Pharmaceutical CXO Introduction

11.20.4 Catalent Revenue in Pharmaceutical CXO Business (2020-2025)

11.20.5 Catalent Recent Development

11.21 Lonza Group AG

11.21.1 Lonza Group AG Company Details

11.21.2 Lonza Group AG Business Overview

11.21.3 Lonza Group AG Pharmaceutical CXO Introduction

11.21.4 Lonza Group AG Revenue in Pharmaceutical CXO Business (2020-2025)

11.21.5 Lonza Group AG Recent Development

11.22 Avid Bioservices

11.22.1 Avid Bioservices Company Details

11.22.2 Avid Bioservices Business Overview

11.22.3 Avid Bioservices Pharmaceutical CXO Introduction

11.22.4 Avid Bioservices Revenue in Pharmaceutical CXO Business (2020-2025)

11.22.5 Avid Bioservices Recent Development

11.23 AbbVie

11.23.1 AbbVie Company Details

11.23.2 AbbVie Business Overview

11.23.3 AbbVie Pharmaceutical CXO Introduction

11.23.4 AbbVie Revenue in Pharmaceutical CXO Business (2020-2025)

11.23.5 AbbVie Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

WuXi AppTec

Tigermed

Charles River Laboratories

Pharmaron

Boehringer Ingelheim

GenScript

MabPlex International

Wuxi Biologics

Jiuzhou Pharma

IQVIA

Syneos Health

PAREXEL

AGC Biologics

FUJIFILM Diosynth Biotechnologies

Patheon

Catalent

Lonza Group AG

Avid Bioservices

AbbVie

Labcorp Drug Development

Shanghai ChemPartner

Pharmablock

Asym Chemical

List of Tables

Table 1. Global Pharmaceutical CXO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CRO

Table 3. Key Players of CMO

Table 4. Key Players of CDMO

Table 5. Global Pharmaceutical CXO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Pharmaceutical CXO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Pharmaceutical CXO Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Pharmaceutical CXO Market Share by Region (2020-2025)

Table 9. Global Pharmaceutical CXO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Pharmaceutical CXO Market Share by Region (2026-2031)

Table 11. Pharmaceutical CXO Market Trends

Table 12. Pharmaceutical CXO Market Drivers

Table 13. Pharmaceutical CXO Market Challenges

Table 14. Pharmaceutical CXO Market Restraints

Table 15. Global Pharmaceutical CXO Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Pharmaceutical CXO Market Share by Players (2020-2025)

Table 17. Global Top Pharmaceutical CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CXO as of 2024)

Table 18. Ranking of Global Top Pharmaceutical CXO Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Pharmaceutical CXO Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Pharmaceutical CXO, Headquarters and Area Served

Table 21. Global Key Players of Pharmaceutical CXO, Product and Application

Table 22. Global Key Players of Pharmaceutical CXO, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Pharmaceutical CXO Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Pharmaceutical CXO Revenue Market Share by Type (2020-2025)

Table 26. Global Pharmaceutical CXO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Pharmaceutical CXO Revenue Market Share by Type (2026-2031)

Table 28. Global Pharmaceutical CXO Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Pharmaceutical CXO Revenue Market Share by Application (2020-2025)

Table 30. Global Pharmaceutical CXO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Pharmaceutical CXO Revenue Market Share by Application (2026-2031)

Table 32. North America Pharmaceutical CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Pharmaceutical CXO Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Pharmaceutical CXO Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Pharmaceutical CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Pharmaceutical CXO Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Pharmaceutical CXO Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Pharmaceutical CXO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Pharmaceutical CXO Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Pharmaceutical CXO Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Pharmaceutical CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Pharmaceutical CXO Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Pharmaceutical CXO Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Pharmaceutical CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Pharmaceutical CXO Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Pharmaceutical CXO Market Size by Country (2026-2031) & (US$ Million)

Table 47. WuXi AppTec Company Details

Table 48. WuXi AppTec Business Overview

Table 49. WuXi AppTec Pharmaceutical CXO Product

Table 50. WuXi AppTec Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 51. WuXi AppTec Recent Development

Table 52. Tigermed Company Details

Table 53. Tigermed Business Overview

Table 54. Tigermed Pharmaceutical CXO Product

Table 55. Tigermed Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 56. Tigermed Recent Development

Table 57. Charles River Laboratories Company Details

Table 58. Charles River Laboratories Business Overview

Table 59. Charles River Laboratories Pharmaceutical CXO Product

Table 60. Charles River Laboratories Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 61. Charles River Laboratories Recent Development

Table 62. Pharmaron Inc Company Details

Table 63. Pharmaron Inc Business Overview

Table 64. Pharmaron Inc Pharmaceutical CXO Product

Table 65. Pharmaron Inc Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 66. Pharmaron Inc Recent Development

Table 67. Labcorp Drug Development Company Details

Table 68. Labcorp Drug Development Business Overview

Table 69. Labcorp Drug Development Pharmaceutical CXO Product

Table 70. Labcorp Drug Development Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 71. Labcorp Drug Development Recent Development

Table 72. Boehringer Ingelheim Company Details

Table 73. Boehringer Ingelheim Business Overview

Table 74. Boehringer Ingelheim Pharmaceutical CXO Product

Table 75. Boehringer Ingelheim Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 76. Boehringer Ingelheim Recent Development

Table 77. GenScript Company Details

Table 78. GenScript Business Overview

Table 79. GenScript Pharmaceutical CXO Product

Table 80. GenScript Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 81. GenScript Recent Development

Table 82. MabPlex International Company Details

Table 83. MabPlex International Business Overview

Table 84. MabPlex International Pharmaceutical CXO Product

Table 85. MabPlex International Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 86. MabPlex International Recent Development

Table 87. Shanghai ChemPartner Company Details

Table 88. Shanghai ChemPartner Business Overview

Table 89. Shanghai ChemPartner Pharmaceutical CXO Product

Table 90. Shanghai ChemPartner Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 91. Shanghai ChemPartner Recent Development

Table 92. Wuxi Biologics Company Details

Table 93. Wuxi Biologics Business Overview

Table 94. Wuxi Biologics Pharmaceutical CXO Product

Table 95. Wuxi Biologics Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 96. Wuxi Biologics Recent Development

Table 97. Pharmablock Company Details

Table 98. Pharmablock Business Overview

Table 99. Pharmablock Pharmaceutical CXO Product

Table 100. Pharmablock Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 101. Pharmablock Recent Development

Table 102. Jiuzhou Pharma Company Details

Table 103. Jiuzhou Pharma Business Overview

Table 104. Jiuzhou Pharma Pharmaceutical CXO Product

Table 105. Jiuzhou Pharma Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 106. Jiuzhou Pharma Recent Development

Table 107. Asym Chemical Company Details

Table 108. Asym Chemical Business Overview

Table 109. Asym Chemical Pharmaceutical CXO Product

Table 110. Asym Chemical Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 111. Asym Chemical Recent Development

Table 112. IQVIA Company Details

Table 113. IQVIA Business Overview

Table 114. IQVIA Pharmaceutical CXO Product

Table 115. IQVIA Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 116. IQVIA Recent Development

Table 117. Syneos Health Company Details

Table 118. Syneos Health Business Overview

Table 119. Syneos Health Pharmaceutical CXO Product

Table 120. Syneos Health Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 121. Syneos Health Recent Development

Table 122. Parexel Company Details

Table 123. Parexel Business Overview

Table 124. Parexel Pharmaceutical CXO Product

Table 125. Parexel Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 126. Parexel Recent Development

Table 127. AGC Biologics Company Details

Table 128. AGC Biologics Business Overview

Table 129. AGC Biologics Pharmaceutical CXO Product

Table 130. AGC Biologics Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 131. AGC Biologics Recent Development

Table 132. FUJIFILM Diosynth Biotechnologies Company Details

Table 133. FUJIFILM Diosynth Biotechnologies Business Overview

Table 134. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product

Table 135. FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 136. FUJIFILM Diosynth Biotechnologies Recent Development

Table 137. Patheon Company Details

Table 138. Patheon Business Overview

Table 139. Patheon Pharmaceutical CXO Product

Table 140. Patheon Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 141. Patheon Recent Development

Table 142. Catalent Company Details

Table 143. Catalent Business Overview

Table 144. Catalent Pharmaceutical CXO Product

Table 145. Catalent Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 146. Catalent Recent Development

Table 147. Lonza Group AG Company Details

Table 148. Lonza Group AG Business Overview

Table 149. Lonza Group AG Pharmaceutical CXO Product

Table 150. Lonza Group AG Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 151. Lonza Group AG Recent Development

Table 152. Avid Bioservices Company Details

Table 153. Avid Bioservices Business Overview

Table 154. Avid Bioservices Pharmaceutical CXO Product

Table 155. Avid Bioservices Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 156. Avid Bioservices Recent Development

Table 157. AbbVie Company Details

Table 158. AbbVie Business Overview

Table 159. AbbVie Pharmaceutical CXO Product

Table 160. AbbVie Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 161. AbbVie Recent Development

Table 162. Research Programs/Design for This Report

Table 163. Key Data Information from Secondary Sources

Table 164. Key Data Information from Primary Sources

Table 165. Authors List of This Report

List of Figures

Figure 1. Pharmaceutical CXO Picture

Figure 2. Global Pharmaceutical CXO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmaceutical CXO Market Share by Type: 2024 VS 2031

Figure 4. CRO Features

Figure 5. CMO Features

Figure 6. CDMO Features

Figure 7. Global Pharmaceutical CXO Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Pharmaceutical CXO Market Share by Application: 2024 VS 2031

Figure 9. Pharmaceutical Companies Case Studies

Figure 10. Biotechnology Companies Case Studies

Figure 11. Pharmaceutical CXO Report Years Considered

Figure 12. Global Pharmaceutical CXO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Pharmaceutical CXO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Pharmaceutical CXO Market Share by Region: 2024 VS 2031

Figure 15. Global Pharmaceutical CXO Market Share by Players in 2024

Figure 16. Global Top Pharmaceutical CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CXO as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical CXO Revenue in 2024

Figure 18. North America Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Pharmaceutical CXO Market Share by Country (2020-2031)

Figure 20. United States Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Pharmaceutical CXO Market Share by Country (2020-2031)

Figure 24. Germany Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Pharmaceutical CXO Market Share by Region (2020-2031)

Figure 32. China Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Pharmaceutical CXO Market Share by Country (2020-2031)

Figure 40. Mexico Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Pharmaceutical CXO Market Share by Country (2020-2031)

Figure 44. Turkey Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Pharmaceutical CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. WuXi AppTec Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 48. Tigermed Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 49. Charles River Laboratories Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 50. Pharmaron Inc Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 51. Labcorp Drug Development Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 52. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 53. GenScript Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 54. MabPlex International Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 55. Shanghai ChemPartner Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 56. Wuxi Biologics Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 57. Pharmablock Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 58. Jiuzhou Pharma Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 59. Asym Chemical Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 60. IQVIA Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 61. Syneos Health Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 62. Parexel Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 63. AGC Biologics Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 64. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 65. Patheon Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 66. Catalent Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 67. Lonza Group AG Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 68. Avid Bioservices Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 69. AbbVie Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pharmaceutical Contract Service Outsourcing Market Research Report 2024

Global Chemical Drug CXO Services Market Research Report 2024

Global Pharmaceutical Contract Sales Outsourcing CSO Market Research Report 2025

Global Pharmaceutical Contract Sales Organization CSO Market Research Report 2025

Global Pharmaceutical CMO Services Market Research Report 2024

Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

CROs Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical CDMO Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Contract Research Organisations CROs Market Research Report 2024

Contract Research Organizations Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Healthcare Contract Research Organizations CRO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical CXO Services Market Research Report 2024

Global Biopharmaceutical CXO Market Research Report 2024

Global Biologics CXO Services Market Research Report 2024

Global Pharmaceutical Products and CMO Market Research Report 2024

Global Biopharmaceutical CMO Services Market Research Report 2024

Contract Research Organization CRO and CDMO for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biologics and Biosimilars CXO Services Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions